Blackbaud, Inc. financials

  1. Home
  2. Financials
  3. BLKB
BLKB CIK 0001280058

Source: EDGAR filings · Built 2026-06-02T02:29:36Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 257.78M 288.53M 194.95M 191.60M 202.00M 118.27M
EBITDA 276.97M -149.71M 155.84M 73.88M 107.32M 129.98M
Working Capital -252.00M -275.46M -266.20M -312.00M -258.66M -194.34M
Net Debt 1.08B 1.05B 796.68M 882.94M 968.58M 525.14M
Gross Margin 58.78% 54.69% 54.11% 52.24% 52.23% 53.13%
Operating Margin 16.91% -23.50% 4.19% -2.69% 2.68% 4.08%
Net Margin 10.19% -25.94% 0.27% -4.29% 0.61% 0.84%
Return on Equity (ROE) 135.17% -236.15% 0.37% -6.10% 0.79% 1.81%
Return on Assets (ROA) 4.81% -12.00% 0.10% -1.52% 0.19% 0.38%
Current Ratio 0.79× 0.78× 0.78× 0.75× 0.77× 0.81×
Debt-to-Equity 13.13× 8.80× 1.02× 1.23× 1.43× 1.32×
Effective Tax Rate 12.76% 4.14% 84.36% 18.30% 19.55% 64.30%
Cash Conversion Ratio 2.31× -0.99× 66.15× -4.49× 37.50× 19.17×
Accruals Ratio -0.06× -0.24× -0.07× -0.08× -0.07× -0.07×
SBC % of Revenue 8.23% 9.09% 11.54% 10.42% 12.98% 9.55%
CapEx Coverage 34.19× 39.76× 42.61× 16.59× 18.32× 4.98×
Free Cash Flow Per Share $5.32 $5.71 $3.63 $3.72 $4.19 $2.43

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 26.72× — 1445.00× — 658.17× 359.75×
P/FCF 11.91× 12.95× 23.89× 15.84× 18.86× 23.70×
FCF Yield 8.40% 7.72% 4.19% 6.31% 5.30% 4.22%
EV / EBITDA 14.57× — 34.95× 54.23× 57.72× 31.01×
P/S 2.62× 3.15× 4.20× 2.95× 5.63× 3.84×
P/B 34.77× 28.70× 5.74× 4.20× 7.29× 8.23×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 1.13B 1.15B 1.11B 1.06B 927.74M 913.22M
Revenues — — — — — 242.61M
Cost of Goods and Services Sold 465.07M 523.20M 508.02M 505.39M 443.19M 428.06M
Gross Profit 663.29M 631.43M 599.05M 552.72M 484.55M 485.15M
Research and Development Expense 138.13M 153.68M 147.47M 156.91M 124.57M 100.15M
Operating Expenses 472.54M 902.80M 552.70M 581.20M 459.64M 447.91M
Operating Income (Loss) 190.75M -271.38M 46.35M -28.48M 24.91M 37.24M
Income Tax Expense (Benefit) 16.81M -12.94M 16.27M -10.17M 1.39M 13.90M
Net Income (Loss) Attributable to Parent 114.97M -299.52M 3.02M -45.41M 5.70M 7.72M
Earnings Per Share, Basic $2.41 $-5.92 $0.06 $-0.88 $0.12 $0.16
Weighted Average Number of Shares Outstanding, Basic 47.68M 50.56M 52.55M 51.57M 47.41M 48.18M
Earnings Per Share, Diluted $2.37 $-5.92 $0.06 $-0.88 $0.12 $0.16
Weighted Average Number of Shares Outstanding, Diluted 48.47M 50.56M 53.72M 51.57M 48.23M 48.70M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 38.91M 67.63M 31.25M 31.69M 55.15M 35.75M
Assets, Current 930.09M 976.59M 929.90M 918.64M 850.97M 819.06M
Assets 2.39B 2.50B 2.91B 2.99B 2.97B 2.04B
Long-term Debt 1.11B 1.08B 781.14M 861.99M 961.17M 534.18M
Liabilities, Current 1.18B 1.25B 1.20B 1.23B 1.11B 1.01B
Long-term Debt, Excluding Current Maturities 1.09B 1.05B 760.40M 840.24M 937.48M 518.19M
Liabilities 2.31B 2.37B 2.10B 2.25B 2.25B 1.62B
Stockholders' Equity Attributable to Parent 85.05M 126.84M 809.90M 744.03M 717.06M 426.15M
Common Stock, Shares, Outstanding 46.71M 49.25M 53.63M 53.07M — —

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 265.55M 295.97M 199.63M 203.89M 213.66M 147.96M
Payments to Acquire Property, Plant, and Equipment 7.77M 7.44M 4.68M 12.29M 11.66M 29.69M
Net Cash Provided by (Used in) Investing Activities -74.94M -73.41M -64.39M -85.55M -471.27M -71.85M
Payments for Repurchase of Common Stock 217.15M 418.03M 18.83M 0 108.42M 41.00M
Payments of Dividends — — — 0 0 5.96M
Net Cash Provided by (Used in) Financing Activities -247.40M -139.35M -142.97M -25.69M 264.11M -10.68M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (BLKB CIK 0001280058), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

AMLX

Amylyx Pharmaceuticals, Inc.

GERN

GERON CORPORATION

PPC

PILGRIM’S PRIDE CORPORATION